Clinical trial
Oncological Outcome After Completing or Abandoning (Radical) Hysterectomy in Patients With Cervical Cancer and Intraoperative Detection of LN Positivity; ABRAX (ABandoning RAd Hyst in cerviX Cancer)
NCT04037124 is registered in ClinicalTrials.gov with General University Hospital, Prague as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oncological Outcome After Completing or Abandoning (Radical) Hysterectomy in Patients With Cervical Cancer and Intraoperative Detection of LN Positivity; ABRAX (ABandoning RAd Hyst in cerviX Cancer)
- Lead sponsor
- General University Hospital, Prague
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2017
- Completion date
- December 1, 2020
- Enrollment
- 718 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.